logo

BAUS Day 3—Going home images and snippets… On the final night of BAUS, I had the honor of giving a dinner talk to the IBUS group—International British Urology Society.  With BAUS c[...]
Achieving the Promise of Digital Health: Are we There Yet? If Not, When…and How? Dr. Robert Wachter Day 2: The 2018 BJUI Guest Lecture: Dr. Robert Wachter.  Achieving the Promise o[...]
BAUS Day 2. The Multidisciplinary Team Debate. Which way are you headed? BAUS is certainly a UK-centric meeting. But we all share most of the same challenges in healthcare, and as [...]
It should surprise no one that I never agreed with the 2012 United States Preventive Services Task Force to give PSA a “D” rating that has led to decreases in U.S. rates of PSA tes[...]
The BJUI supports clinical trials. Plain, simple, and with some new strategies. Randomised clinical trials (RCTs) are the highest level of evidence-based medicine. We know this to [...]
In this month’s issue of the BJUI, we highlight the evolving era of immunotherapy in solid tumour therapy. As urological surgeons, we spend a large portion of our time workin[...]
Sequencing robot-assisted extended pelvic lymph node dissection prior to radical prostatectomy: a step-by-step guide to exposure and efficiency Stephen B. Williams, Yasar Bozkurt ,[...]
Intraoperative in vivo tracking of a periprostatic nerve with multiphoton microscopy in rat model. In the last 6 months, the BJUI editorial team has evaluated an average of 59 urol[...]
Secretary Generals to the big Spring Meetings, European Association of Urology and the American Urological Association Every Spring, thousands of urologists gather in big cities wi[...]